Analysis Note

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

Application

This pharmaceutical secondary standard can also be used as follows:Simultaneous estimation of lidocaine hydrochloride, tribenoside, and their related compounds in pharmaceutical formulations by high-performance liquid chromatography (HPLC) combined with a UV/Vis detectorMulti-analysis of dexpanthenol, lidocaine hydrochloride, mepyramine maleate, and their related impurities in their combined dosage forms by high-performance liquid chromatography (HPLC)-diode array detectionDevelopment of an HPLC method for the estimation of three active pharmaceutical ingredients along with their impurities in a semi-solid topical formulation

Footnote

To see an example of a Certificate of Analysis for this material enter LRAC2078 in the slot below. This is an example certificate only and may not be the lot that you receive.

General description

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.Lidocaine Related Compound H is one of the impurities of the local anesthetic lidocaine found in bulk powder and dosage forms.

Other Notes

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.